Durable, potentially curative therapies for genetic disorders and cancer have arrived. Short—even single dose—treatment regimens yield lasting health benefits, but large single payments will challenge the current reimbursement system. Policy, regulations, and business operations need to evolve to enable emerging solutions.

In this virtual conference the FoCUS Project shares research and solutions to the challenge of paying for high cost durable and curative therapies. You will leave understanding the estimated clinical trial pipeline of these types of therapies and their potential impact on the healthcare system. This intensive 1-day conference will help you:

• Understand the expected impact of the therapy pipeline
• Learn to leverage tools to help determine how your plan could be affected
• Become fluent in potential frameworks and issues for implementing cell and gene therapy financing agreements

This interactive workshop is ideal for:

• Public and private insurers
• Healthcare consultants and analysts
• Patient advocates
• Pharma / biotech strategists